Abstract
Diffuse advanced peritoneal carcinomatosis with malignant ascites leads to a rapid deterioration of patients general conditions and changes the quality of life for the worse. Only a few publications deal with the natural history of peritoneal carcinomatosis. The median survival for patients with peritoneal carcinomatosis, especially in combination with malignant ascites, is short: 1.5 months for pancreatic cancer patients, 2.5–4.0 months for gastric cancer patients, and 4.0–6.0 months for colon cancer patients. In contrast to the well-known superior median survival time in ovarian cancer stage FIGO III, a subgroup of patients with gross peritoneal carcinomatosis and malignant ascites will not survive more than 4.4 months.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fujimoto S, Shrestha RD, Kokobun M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Y, Mizutani M, Chikenji T, Okui K. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212:592–596.
Jaquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72:1631–1636.
Los G, Sminia P, Wondergem J, Mutsaers P, Havemen J, Huinink D, Smals O, Gonzalez-Gonzalez D, McVie JG. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 1991;27:472–477.
Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41: 1096–1099.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Kober, F., Heiss, A., Roka, R. (1996). Diffuse and gross peritoneal carcinomatosis treated by intraperitoneal hyperthermic chemoperfusion. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1247-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1247-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8531-1
Online ISBN: 978-1-4613-1247-5
eBook Packages: Springer Book Archive